Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children

• Published in: Journal of Clinical Microbiology Vol. 28; no. 10; pp. 2327 - 2330
• Main Authors: ENGLUND, J. A, ARVIN, A. M, BALFOUR, H. H
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01-10-1990
• Subjects: Acyclovir - therapeutic use; Adolescent; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antibodies, Viral - blood; Antiviral agents; Biological and medical sciences; Chickenpox - drug therapy; Chickenpox - immunology; Child; Child, Preschool; Herpesvirus 3, Human - immunology; Humans; Immunoglobulin G - biosynthesis; Medical sciences; Pharmacology. Drug treatments; Viral Proteins - immunology; Human; Therapeutic efficiency; Varicella zoster virus; Immune response; Herpesviridae; Alphaherpesvirinae; IgG; Glycoproteins; Virus; Proteins; Treatment; Antiviral; Serum; Child; ELISA assay; Humoral immunity
• ISSN: 0095-1137; 1098-660X
• DOI: 10.1128/jcm.28.10.2327-2330.1990

Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • [e-mail]
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.  
For an alternate route to
JCM
.asm.org, visit:
JCM